For the Quarter Ending December 2022
In North America, the CFR Los Angeles price of Orlistat API rose from $393500/mt to $396800/mt in October and November before dropping to $388500/mt in December of 2022. The first week of October saw a delay in Orlistat imports due to a one-week holiday in China, a significant exporter; nonetheless, ample supplies held by domestic retailers and strong demand maintained the market's buoyancy. Because of the unanticipated increase in Covid cases in China that had a negative effect on the US Orlistat market, the market for Orlistat experienced a pattern change in the second half of the quarter. The broken supply chain did, however, gradually heal as the economy expanded, and there was a major decrease in port backlog in December.
During the fourth quarter of 2022, the price of Orlistat across the Asia Pacific region showed a stagnant market trend. FOB Shanghai values in China first increased from $380000/mt to 382550/mt in October and November before falling to $374200/mt in December. The closure of production facilities for the Golden Week resulted in a gradual fall in Orlistat orders for China's API market during the first week of October. After a one-week celebration and market reopening, domestic traders had to deal with various discordant signals, making it difficult for the players to catch up to the slow growth observed in some downstream sectors, but strong demand kept the market afloat. Due to plentiful supplies, Chinese producers and suppliers could satisfy demand throughout the entire quarter. In reaction to criticism and severe discontent in the country, government authorities changed its zero-covid regulations, making the country susceptible once more during the H2 of Q4 2022.
In Europe, given the settlement of CFR Hamburg prices at $391520/mt and $383280/mt in November and December, the German market for Orlistat followed the same trend as that of North America and Asia. Because of the unanticipated rise in COVID cases, which resulted in a continuous fall in demand, international demand was higher in the first part of the quarter than it was in December. Orlistat offtakes remained strong in the end-user industries despite high energy and raw material prices.
For the Quarter Ending September 2022
The prices of Orlistat inclined significantly with a positive trend during the first half of Q3 in the North American region, which was supported by higher downstream demand and inquiries from the domestic market. Further, the prices started to decline following the mid-Q3 and stabilized towards the termination of the third quarter on an upper side backed by consistent requirements. Also, the local vendor had enough inventories to meet the overall demand. Eliminating the lockdown and resumption of production activities in the exporting countries kept the trading momentum firm in the international market. Overall, in the third quarter, Orlistat prices decreased with the settlement of USD 391000/MT CFR Los Angeles in the United States.
In the APAC region, the prices of Orlistat inclined significantly during the third quarter of 2022. During the H1 of Q3, the prices rose considerably at a stable rate owing to consistent demand from end-user pharmaceutical sectors and weakened inventories with the domestic market participants. Furthermore, following the H2 of Q3, the halt in production activities and port congestion led to accumulated shipments which supported the pricing tendency in the market. Moreover, towards the termination of Q3, the prices declined considerably, keeping enough inventories with the local vendor to meet the overall demand. With this, the prices of Orlistat were assessed at USD 377000/MT FOB Shanghai in China.
The prices of Orlistat witnessed a downward price trajectory in the European region during the third quarter of 2022. At the onset of Q3, the costs increased slightly compared to the previous month, in which the market participant had stockpiled inventories and could meet the demand side. There were balanced supply-demand market sentiments observed during the H1 of Q3. Further, towards the H2 of Q3, the prices started to decline significantly, keeping the market sentiments on the lower side. Additionally, the already challenging economic climate in Europe and the lockdown and port restrictions in China made the availability of downstream Orlistat in the Europen region even more complicated, supporting Orlistat's price tendency in Germany. With this, the prices of Orlistat were assessed at USD 385450/MT CFR Hamburg.
The North American region showcased a increasing price trend of Orlistat API in the market during the second Quarter of 2022. The resurgence of the covid-19 pandemic in China resulted in a temporary lockdown, causing the shutdown of Industries and positively affecting the prices of Orlistat in the market. Furthermore, the increased downstream demand from Various Pharma and biopharmaceutical industries resulted in upsurged Orlistat prices in the market. Moreover, the increased upstream derivative Lipstatin prices resulted in the price increament downstream Orlistat. Since the lockdown imposed in China, trading activities were hampered, causing freight charges to rise, increasing the prices of Orlistat. In addition, the prices surged at the end of the second quarter i.e., in June with the settlement of USD 386500/MT CFR Los Angeles in Untied States.
The Orlistat market showcased a escalated sentiment in its prices during the second Quarter of 2022 in the Asia Pacific region, backed by increased downstream demand observed amid the resurgence of the Covid-19 pandemic in China. Furthermore, the increased trading activities observed from China to other regions affected the market positively in Orlistat prices. Increased demand resulted in shortage of inventories with the suppliers in the domestic market, primarily affecting orlistat prices. Towards the termination of the second Quarter in June, the price surged as the demand increased, leading to a shortage of Inventories. Hence, the China Market settled at USD 370000/MT FOB Shanghai in June.
In the Second Quarter of 2022, the Europe Orlistat API market showcased mixed sentiments. The increased downstream demand from various pharmaceutical and Biopharmaceutical industries resulted in the price increase of Orlistat. The strong buying activities observed in the domestic market resulted in Orlistat API's price increment. Additionally, prices for Upstream derivative lipstatin added another factor that results in orlistat price increase in the market. Furthermore, with the termination of Q2 the prices recorded for Orlistat in Germany with declining tendency was settled at USD 425130/MT CFR Hamburg.